InfuSystem (NYSE: INFU) to release Q1 2026 results and host call
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
InfuSystem Holdings, Inc. announced it will release its first quarter 2026 financial results on May 7, 2026, before the market opens. On the same day, the Company will host a conference call at 9:00 a.m. Eastern Time for investors and other interested parties.
Participants can join by phone or via a live webcast in the Investors section of InfuSystem’s website, with a telephone and online replay available through May 14, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Q1 2026 results release date: May 7, 2026
Conference call time: 9:00 a.m. Eastern Time
Replay availability end date: May 14, 2026
+3 more
6 metrics
Q1 2026 results release date
May 7, 2026
First quarter 2026 financial results will be issued before market open
Conference call time
9:00 a.m. Eastern Time
Investor call on May 7, 2026 to discuss Q1 2026 results
Replay availability end date
May 14, 2026
Telephone and online replay of conference call available through this date
Domestic dial-in number
(833) 366-1127
Investor access number for the live Q1 2026 conference call
International dial-in number
(412) 902-6773
Alternative access number for the live Q1 2026 conference call
Replay access code
1097864
Code required for telephone replay of the Q1 2026 conference call
Key Terms
Regulation FD Disclosure, conference call, Inline XBRL, durable medical equipment, +2 more
6 terms
Regulation FD Disclosure regulatory
"The information furnished in this Item 7.01 — “Regulation FD Disclosure”"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
conference call financial
"The Company will also conduct a conference call for all interested investors"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
durable medical equipment medical
"facilitating outpatient care for durable medical equipment manufacturers and health care providers"
Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.
Patient Services financial
"The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses."
Device Solutions financial
"The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales"
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 30, 2026
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices) (Zip Code) | ||||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
Not Applicable | ||||||||
(Former Name or Former Address, if Changed Since Last Report) | ||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 - Regulation FD
On April 30, 2026 , InfuSystem Holdings, Inc. (the “Company”) issued a press release announcing that the Company will disclose its financial results for the first quarter 2026 on Thursday, May 7, 2026 before the market opens. The Company will also conduct a conference call for all interested investors on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information furnished in this Item 7.01 — “Regulation FD Disclosure” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 9.01 - Financial Statements and Exhibits
(d) Exhibits
Exhibit No. | Description | |||||||
99.1 | Press Release of InfuSystem Holdings, Inc. dated April 30, 2026 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INFUSYSTEM HOLDINGS, INC. | |||||
By: | /s/ Carrie Lachance | ||||
Carrie Lachance | |||||
Chief Executive Officer and Director | |||||
Dated: April 30, 2026
Exhibit 99.1
 | InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 | ||||
FOR IMMEDIATE RELEASE
CONTACT: Barry Steele
Chief Financial Officer
248-260-2211
InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026
Investor Conference Call to be held 9:00 a.m. Eastern Time
Rochester Hills, Michigan, April 30, 2026 — InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2026 financial results on Thursday, May 7, 2026, before the market opens.
The Company will also conduct a conference call for all interested parties on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 1097864 through Thursday, May 14, 2026.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
####
FAQ
When will InfuSystem (INFU) report its first quarter 2026 results?
InfuSystem plans to release its first quarter 2026 financial results on May 7, 2026, before the market opens. The company will also host a conference call that morning to discuss the results in more detail with interested participants.
What time is InfuSystem’s Q1 2026 earnings conference call?
InfuSystem’s conference call to discuss first quarter 2026 results is scheduled for 9:00 a.m. Eastern Time on May 7, 2026. Investors and other interested parties can dial in or listen via a live webcast through the company’s investor relations website.
How can investors access InfuSystem’s Q1 2026 earnings call replay?
A replay of InfuSystem’s Q1 2026 earnings call will be available through May 14, 2026. Listeners can access the replay via the company’s investor relations website or by phone using the specified replay access code provided in the announcement.
What services does InfuSystem (INFU) provide according to this filing?
InfuSystem is described as a leading national health care service provider facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its two platforms are Patient Services, covering therapies like oncology and pain management, and Device Solutions, offering rentals, sales, and biomedical services.
Where is InfuSystem headquartered and where does it operate Centers of Excellence?
InfuSystem is headquartered in Rochester Hills, Michigan. It also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas, and Ontario, Canada, supporting its national healthcare service operations and local, field-based customer support network.